Document text
Principal Investigator: Jessica Manning
Organization: NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Fiscal Year: 2021
Award: $98,893
Funding agency: National Institute of Allergy and Infectious Diseases
METAGENOMIC CHARACTERIZATION OF SARS-COV-2 AND ITS VARIANTS AID CAMBODIAN PUBLIC HEALTH RESPONSE TO COVID19 PANDEMIC.
NIAID Cambodia ICER quickly repurposed an existing metagenomics pipeline, originally set up for vector-borne diseases, to genetically characterize index cases of COVID-19 in January 2020. At this early pre-pandemic timepoint, sequencing COVID-19 cases was critical given the SARS-CoV-2 genetic diversity in humans and animals was not completely known, and thus mutation rates and the consequences thereof were not understood. Further, non-specificity of tests combined with variable sample quality limited confidence in field diagnostics. Despite limited sequencing capacity in-country, ICER Cambodia successfully identified and sequenced the novel SARS-CoV-2 pathogen, after developing enrichment methods to overcome handicaps of low coverage of the genome. Since that time, ICER Cambodia has upgraded to a NextSeq 2000 that allows full recovery of SARS-CoV-2 genomes without enrichment or amplicon-based methods. We have assisted the Royal Cambodian Governments Ministry of Health in sequencing several outbreaks for containment and mitigation of SARS-CoV-2 in Cambodia and have expanded the NIAID collaboration to include the Cambodian Communicable Disease Center.
MALARIA-EXPERIENCED CAMBODIANS DEMONSTRATE HIGHER-THAN-EXPECTED SARS-COV-2 SEROPOSITIVITY.
Southeast Asians are exposed to pathogens, zoonotic and otherwise, that may influence SARS-CoV-2 seroreactivity. We performed a pre-pandemic (2005 to 2011) serosurvey of 528 malaria-experienced Cambodians. Our results demonstrated higher-than-expected (up to 13.8%) positivity of non-neutralizing IgG to SARS-CoV-2 spike and RBD antigens. This SARS-CoV-2 serological cross-reactivity is linked to higher AMA-1 antibody levels, a marker of malaria immunity and is not associated with levels of common cold respiratory betacoronaviruses. However, it is possible other zoonotic betacoronavirus exposure (e.g. from common agriculture practice with bat guano) may also contribute to the cross-reactivity. These findings have implications for interpreting large-scale SARS-CoV-2 serosurveys from malaria-endemic areas and understanding the diversity of coronavirus exposure in Southeast Asia.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><7S Gamma Globulin><Acute Nasopharyngitis><Agriculture><Animals><Antibodies><Antigens><Area><Bats><COVID crisis><COVID epidemic><COVID pandemic><COVID-19><COVID-19 crisis><COVID-19 epidemic><COVID-19 genome><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 immunity><COVID-19 outbreak><COVID-19 pandemic><COVID-19 public health crisis><COVID-19 virus><COVID-19 virus genome><COVID19><COVID19 crisis><COVID19 epidemic><COVID19 genome><COVID19 global health crisis><COVID19 global pandemic><COVID19 health crisis><COVID19 immunity><COVID19 outbreak><COVID19 pandemic><COVID19 public health crisis><COVID19 virus><COVID19 virus genome><CV-19><CV19><Cambodia><Cambodian><Chiroptera><CoV-2><CoV2><Collaborations><Common Cold><Communicable Diseases><Communities><Containment><Coronaviridae><Coronavirus><Country><Detection><Diagnostic><Disease><Disease Outbreaks><Disorder><Early Diagnosis><Exposure to><Functional Metagenomics><Genetic Alteration><Genetic Change><Genetic Diversity><Genetic Variation><Genetic defect><Genome><Government><Health><Human><IgG><Immunity><Immunoglobulin G><Infectious Disease Pathway><Infectious Diseases><Infectious Disorder><Infrastructure><International><Kampuchea><Khmer Republic><Link><Malaria><Metagenomics><Methods><Modern Man><Mutation><NIAID><National Institute of Allergy and Infectious Disease><Outbreaks><Paludism><Plasmodium Infections><Population><Public Health><Recovery><Risk><SARS corona virus 2><SARS-CoV-2><SARS-CoV-2 epidemic><SARS-CoV-2 genome><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 immunity><SARS-CoV-2 outbreak><SARS-CoV-2 pandemic><SARS-CoV2><SARS-CoV2 epidemic><SARS-CoV2 genome><SARS-CoV2 outbreak><SARS-CoV2 pandemic><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Sampling><Serology><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 immunity><Severe acute respiratory syndrome coronavirus 2 outbreak><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome related corona virus 2><Southeast Asia><Southeastern Asia><Testing><Time><Variant><Variation><Vector-borne disease><Vector-borne infectious disease><Vector-transmitted disease><Vector-transmitted infectious disease><Wuhan coronavirus><Zoonoses><Zoonotic><Zoonotic Infection><agricultural><base><beta CoV><beta coronavirus><betaCoV><betacoronavirus><corona virus><corona virus disease 2019><corona virus disease 2019 epidemic><corona virus disease 2019 pandemic><coronavirus disease 2019><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 genome><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 immunity><coronavirus disease 2019 outbreak><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease 2019 virus><coronavirus disease 2019 virus genome><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><cross reactivity><diagnostic platform><diagnostic system><early detection><emerging pathogen><experience><genome mutation><genomic epidemiology><global health><hCoV19><immunity against COVID-19><immunity against COVID19><immunity against SARS-CoV-2><immunity against Severe acute respiratory syndrome coronavirus 2><immunity against coronavirus disease 2019><immunity to COVID-19><immunity to COVID19><immunity to SARS-CoV-2><immunity to Severe acute respiratory syndrome coronavirus 2><immunity to coronavirus disease 2019><immunogen><indexing><innovate><innovation><innovative><nCoV2><new pathogen><novel><novel pathogen><pandemic><pandemic disease><pathogen><respiratory><response><serology survey><serosurvey><severe acute respiratory syndrome coronavirus 2 genome><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><southeast Asian><vector-borne illness><vectorborne disease><vectorborne illness><vectorborne infectious disease><β CoV><β coronavirus><βCoV>